Diabetes Clinical Trial
— KADFUTOfficial title:
A Prospective Single Blind Randomised Controlled Study to Compare the Outcomes of Patients With Diabetes and Clinically Non-infected Neuro-ischaemic and Neuropathic Foot Ulcers Treated With and Without Oral Antibiotics.
The overall objective is to investigate whether antibiotics in the treatment of clinically
clean neuropathic and ischaemic ulcers in diabetic foot patients could reduce the incidence
of infection and therefore lead to improved outcomes This is a single centre study in which
patients with either type 1 or 2 diabetes mellitus, who consecutively present to the
Diabetic Foot Clinic [DFC] with clean neuropathic (NU) or ischaemic (IU) diabetic foot ulcer
without clinical signs of infection will be invited to take part and will express their
willingness to take part in the study by signing a consent form.
- All patients will be treated and followed up in the DFC at King's College Hospital.
Patients will be randomised into two groups: an antibiotic group and a control group.
- The antibiotic group will receive standard treatment along with antibiotics.
- The control group will have standard treatment alone.
- Patients from both groups will be reviewed at weekly intervals for a period of 20
weeks.
- Patients will be removed from the study if they develop clinical signs of infection or
if their ulcer heals prior to 20 weeks but will be followed up via routine practice for
eventual outcomes
Status | Not yet recruiting |
Enrollment | 166 |
Est. completion date | February 2012 |
Est. primary completion date | February 2012 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 85 Years |
Eligibility |
Inclusion Criteria: - Patients will be eligible for study participation if he or she meets the following criteria - Male or female age 18-85 years inclusive - Have been diagnosed with Type 1 or Type 2 diabetes - Must be able to speak and understand English and be able to provide meaningful written informed consent . - If female, is nonpregnant (negative pregnancy tests at the baseline visit) and nonlactating. - If female, is either not of childbearing potential (defined as postmenopausal for = 1 year or surgically sterile [bilateral tubal ligation, bilateral oophorectomy or hysterectomy]) or practising one of the following medically-acceptable methods of birth control and agrees to continue with the regimen throughout the duration of the study: - Oral, implantable or injectable contraceptives for 3 consecutive months before the baseline visit. - Total abstinence from sexual intercourse (= 1 complete menstrual cycle before the baseline visit). - Intrauterine device - Double barrier method (condoms, sponge, diaphragm or vaginal ring with spermicidal jellies or cream) - Present with one or more diabetic foot ulcers on or below the malleoli with no clinical signs of infection (using the Infectious Disease Society of America/International Working Group on the Diabetic Foot Guidelines). Exclusion Criteria: - Female subjects who are pregnant or breast feeding - Any known intolerance or allergy or reported adverse reaction to any antibiotics - Known osteomyelitis - Patients with foot ulcers with clinical signs of infection - Ulceration caused primarily by a disease other than diabetes. - Any other serious disease likely to compromise the outcome of the trial. - Evidence of critical renal disease (creatinine >300µmol/L) - Patients taking immunosuppressants or any other preparation which may interfere with healing. - Participation in another clinical trial in the previous 28 days |
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Single Blind (Caregiver), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
King's College Hospital NHS Trust |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Time to healing of foot ulceration in each group | 20 weeks | No | |
Secondary | • Percentage of patients who will develop clinical signs of infection over a follow up period of 20 weeks | 20 weeks | No | |
Secondary | • Percentage of patients in each group that are healed at 20 weeks. | 20 weeks | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05594446 -
Morphometric Study of the Legs and Feet of Diabetic Patients in Order to Collect Data Intended to be Used to Measure by Dynamometry the Pressures Exerted by Several Medical Compression Socks at the Level of the Forefoot
|
||
Completed |
NCT03975309 -
DHS MIND Metabolomics
|
||
Completed |
NCT01855399 -
Technologically Enhanced Coaching: A Program to Improve Diabetes Outcomes
|
N/A | |
Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
Recruiting |
NCT04984226 -
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
|
Phase 2 | |
Recruiting |
NCT05007990 -
Caregiving Networks Across Disease Context and the Life Course
|
||
Active, not recruiting |
NCT04420936 -
Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our Program
|
N/A | |
Recruiting |
NCT03549559 -
Imaging Histone Deacetylase in the Heart
|
N/A | |
Completed |
NCT04903496 -
Clinical Characteristics and Disease Burden of Diabetic Patients Based on Tianjin Regional Database
|
||
Completed |
NCT01437592 -
Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT03390179 -
Hyperglycemic Response and Steroid Administration After Surgery (DexGlySurgery)
|
||
Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
Recruiting |
NCT05294822 -
Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes
|
N/A | |
Completed |
NCT04427982 -
Dance and Diabetes/Prediabetes Self-Management
|
N/A | |
Completed |
NCT02356848 -
STEP UP to Avert Amputation in Diabetes
|
N/A | |
Completed |
NCT03292185 -
A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects
|
Phase 1 | |
Active, not recruiting |
NCT05477368 -
Examining the Feasibility of Prolonged Ketone Supplement Drink Consumption in Adults With Type 2 Diabetes
|
N/A | |
Completed |
NCT04496401 -
PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus
|
Phase 4 |